Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

Dallas VA Medical Center

Status

Terminated

Conditions

Cancer Recurrence

Solid Tumors

Treatments

Procedure: PET/CT

Procedure: NCCN recommendations for solid tumor post treatment

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT00954148

09-017

Details and patient eligibility

About

This is a comparison, at this VA Hospital,of routine multi-visit and multi-testing for solid tumor recurrence in four tumor groups to a limited scheduled 5 visit history/physical with PET/CT only, over a five year period. The purpose is to show through utilization of the single most sensitive and specific test currently available-PET/CT-that survival for patients in follow-up can be improved.(Plus lowering medical costs and increasing patient confidence and compliance with follow-up appointments).

Full description

Routine visits would include COLON:14 visits with cea and 6 CTs over a 5 year period plus PET/CT at last visit RECTAL: 14 visits with cea and 6 CTs and 4 procto exams over 5 year period plus PET/CT at last visit HEAD/NECK: 14 visits with 4 CTs and PET/CT at last visit LUNG:12 visits plus 4 CTs and PET/CT at last visit

Limited follow-up ALL GROUPS: a history and physical plus PET/CT at 3 month, 9 month, 18 month, 36 month and 60 month only

Enrollment

53 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Completed primary therapy such that no disease is evident at the time of enrollment in the study

Exclusion criteria

Patients unable to consent
Without diagnosis of colorectal cancer
Non-small cell lung cancer or squamous cell cancer of the head and neck
Unwilling or unable to participate in the assigned follow-up program
Having a serum glucose at time of PET/CT greater than 180mg/dl
Stage IV disease or with evidence of disease recurrence post treatment
Who are not a candidate for further treatment should a recurrence of disease be identified